Journal
Spotlights
Webinars
Channels
Analytics
Manufacturing
Vectors
Regulatory
Supply Chain
Translational Research & Clinical Development
Business and Finance
Reports
Regulatory Insights
Clinical Trends
Innovation Insights
Business Insights
Investor Insights
FastFacts
Media Kit
Media Kit
Editorial calendar
Sponsorship opportunities
Webinars
About
Submit your manuscript
Meet the team
Get in touch
Immuno-Oncology Insights
Login
Register
Update your profile
Logout
CELL & GENE THERAPY
INSIGHTS
Gene therapy CMC and quality control
October 2021
Sponsors
Download full spotlight
Are you finishing strong in cell therapy manufacturing? Tackling your final fill and finish challenges with automation
D Sethi,
A Cunningham
4 November 2021
Webinar Digest
Read more
Expression systems for viral vector production: advantages of the Sf9 baculovirus system and simple solutions to address its specific analytical challenges
Y Li,
S Kashi Ranganath
25 October 2021
Innovator Insight
Read more
Analytical toolkit for rapid formulation development of rAAV gene therapies
J Wei,
Y Cai,
J Warren
21 October 2021
Expert Insight
Read more
Challenges in AAV manufacturing: the interplay of process variations, in-process characterization, and drug product quality
D Chu,
H Acharya,
E Springfield
et al.
20 October 2021
Expert Insight
Read more
Gene therapy CMC and quality control
C Bec
20 October 2021
Foreword
Read more
The Chemistry Manufacturing and Controls (CMC) section of gene therapy-based INDs: overview in a changing landscape
G Denning
17 October 2021
Expert Insight
Read more
Advancing real-time monitoring of AAV vector processes
R Legmann,
J Ferraiolo
12 October 2021
Interview
Read more
Advancing real-time monitoring of AAV vector processes
R Legmann,
J Ferraiolo
10 October 2021
Podcast
Listen now
Next steps in the evolution of AAV vector characterization technologies
E Ayuso
4 October 2021
Interview
Read more
Addressing challenges in characterizing novel AAV capsids and gene editing platform-driven therapeutics
L Drouin
1 October 2021
Interview
Read more
Considerations for developing scalable and efficient collection network processes
Lacey Anderson, Senior Manager, Collection Network Management, Be The Match BioTherapies
Sara Butler, Network Liaison, Be The Match BioTherapies
Allison Montalvo, , Program Manager, Oncology, Janssen ( A division of J&J)
28 October 2021
Webinar
Watch now
Optimization of AAV production for high-yielding and scalable GMP processes
Claire Wartel-Weill, Director of Quality and Compliance, Polyplus-transfection
Mathieu Porte, BioProduction R&D Manager, Polyplus-transfection
Bhargavi Kondragunta, Director of Internal R&D & Product Development, Catalent
George Buchman, PhD, Vice President, Pre-Clinical and Process Development, Catalent Cell & Gene Therapy
20 October 2021
Webinar
Watch now
×
Please enter your email to register
Register